日時： 2003年1月15日（水）15:00-18:00 14:30開場
松本 正 氏：バイオベンチャー成功の秘訣
Strengthening the Climate for Corporate Venturing
15:10-16:10 特別講演（松本 正 氏）
16:40-17:40 MIT講演（Ken Morse氏）
Ken Morse leads the MIT effort to train leaders to bring innovative concepts and technologies to market and build successful high tech startup businesses. Based at the MIT Sloan School of Management, the MIT Entrepreneurship Center has the mandate to teach High Tech Entrepreneurship and to foster research and collaboration, Institute-wide. The student-run $50K Entrepreneurship Competition, as well as enrollment in New Enterprises and the Entrepreneurship Laboratory Courses, are open to students from Engineering, Science, and Management, encouraging multidisciplinary teamwork. Morse joined MIT in 1996 after 25 years as a serial entrepreneur helping launch six high-tech ventures.
Between 1982 and 1996, Morse held a number of strategic positions in a venture-backed startup, Aspen Technology, Inc., which commercialized process modeling software originally developed at MMIT. He initially crafted the company’s global strategy and secured early customers in Europe and Asia. As a member of AspenTech’s Board of Directors from 1986 until 1995, he focused on AspenTech’s entry into new global markets, including high value applications of their enterprise software. From 1992 to 1996, he resided in Brussels as AspenTech’s Managing Director for Europe, Middle East and Africa where he opened and managed new offices in France, Germany, Italy, Switzerland and South Africa, as well as integrating the European businesses acquired by AspenTech.
After a highly successful initial public offering (IPO) in October 1994, AspenTech has grown to 1600+ employees worldwide, with revenues exceeding $150 million. Morse continues to advise AspenTech on global new business initiatives, particularly in supply chain management for the Chemical, Pharmaceutical, and Pulp and Paper industries.
Ken’s interest in international high tech ventures began at MIT, where he graduated with a BS in Political Science in 1968. Following graduation, as President of AIESEC-US and an International Advisory Committee Officer for this global business student exchange program, he traveled widely on behalf of AIESEC before entering Harvard Business School. Morse received his MBA with honors in 1972 and joined Schroders, the UK-based merchant bank, where he worked directly for Jim Wolfensohn, now President of the World Bank.
In 1975 Morse formed a trading company under the aegis of Chase Manhattan Bank to assist U.S. technology-based companies to enter emerging Asian markets. He lived in Beijing for five years during the latter half of the Cultural Revolution. As President of Chase Pacific Trade Advisors, he assisted IBM, General Motors, Hughes Aircraft, Measurex, Mine Safety Appliances, and Waters Associates to enter China and other developing markets.
In 1980, Morse relocated to Silicon Valley as a founding member of 3Com Corporation, where he was employee #8. He helped raise the initial venture funding and served as the first head of sales, marketing, and planning. After a successful launch he returned to the Boston area where he has been a founder of several other MIT-related startup ventures including Applied Expert Systems, Inc. (a spinout frrom Index Systems), Organogenesis, and others.
Ken is a member of the Council on Foreign Relations, the World Affairs Council, the Cercle Royal Gaulois Artistique & Literaire (Brussels), and the Quissett Yacht Club. Prior to moving to Brussels, Ken was a member of the Board of the MIT Enterprise Forum of Cambridge®. He currently serves on the Board of Directors of Optimum Logistics Ltd.
He serves as the Émile Bernheim Visiting Professor in Entrepreneurship, Solvay Business School, Université Libre de Bruxelles (ULB) (Brussels, Belgium) for the academic year 2001-2002.
Mass High Tech named Ken “High Tech All-Star” for his contribution to entrepreneurship education.
When time permits, Ken and his family enjoy tennis and sailing their wooden boat.
1982年 米国National Institute of Health派遣（１年半）
米国にReqMed Research, Inc.を設立し、President & CEOに就任
Dr. Matsumoto has more than 20 years of experience in the life science industries. He is a co-founder and the President and CEO of ReqMed Company, Ltd. since 1998. Dr. Matsumoto played a key role in helping to create the pioneer Japanese biotech fund, Life Science Venture Fund, of which ReqMed Company, Ltd. is a General Partner. He is also the founder and President and CEO of ReqMed Research, Inc. since November 2000. Currently, Dr. Matsumoto also serves as Chairman of the Board of Directors for both ReqMed Company, Ltd. and ReqMed Research, Inc. He also serves on X-mine’s Board of Directors as a Director. Prior to co-founding ReqMed, Dr. Matsumoto was involved with Research and Business Management at Kyowa Hakko Kogyo Co., Ltd. and held several key positions from 1986 – 1998. He has served at Kyowa as the Manager of Licensing and Business Development, Manager of Strategic Planning Department, and Manager of Pharmaceutical R&D Center of the International Division where he was involved in forming collaborations with major biopharmaceutical companies such as COR and Cephalon. Dr. Matsumoto has also held several Researcher positions at Kyowa as well. He was a Researcher at Kato Memorial Bio- Science Laboratories from April 1986 ? March 1989 where he researched new trends in Neuroscience for Kyowa. From April 1983 September 1984, Dr. Matsumoto worked as a Researcher at the National Institute of Mental Health in the United States on LCB, an anti-inflammation protein. Prior to NIH, Dr. Matsumoto worked as a Researcher at the Tokyo Research Laboratories from April 1981 March 1986 on establishing a high level of gene expression in E.coli and the isolation of new c-DNAs related to inflammation diseases. Dr. Matsumoto received his B.S., M.S., and Ph.D. from the Faculty of Pharmaceutical Science at the University of Tokyo and received his MBA from Tsukuba University. Dr. Matsumoto’s hobby is sushi. He is a sushi connoisseur and enjoys sharing his knowledge of the art with others.